Low-frequency (1Hz) repetitive transcranial magnetic stimulation (rTMS) reverses Aβ1-42-mediated memory deficits in rats

Experimental Gerontology

Volumn 48, Issue 8, 2013, Pages 786-794

  Tan, Tao ^a   Xie, Jiacun ^a   Liu, Tiaotiao ^a   Chen, Xiaojia ^a   Zheng, Xiaobo ^a   Tong, Zhiqian ^c   Tian, Xin ^a,b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b Tianjin Binhai Neurological Institute   (China)

^c INSTITUTE OF BIOPHYSICS   (China)

Author keywords

Alzheimer's disease (AD); Brain derived neurotrophic factor (BDNF); Long term potentiation (LTP); Nerve growth factor (NGF); NMDA receptor; Repetitive transcranial magnetic stimulation (rTMS)

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; BRAIN DERIVED NEUROTROPHIC FACTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NERVE GROWTH FACTOR; NEUROTROPHIN; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA-PROTEIN (1-42); PEPTIDE FRAGMENT;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELISA KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; LONG TERM POTENTIATION; MALE; MAZE TEST; NON INVASIVE PROCEDURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPATIAL MEMORY; TRANSCRANIAL MAGNETIC STIMULATION; UPREGULATION; WESTERN BLOTTING; ALZHEIMER'S DISEASE (AD); ANIMAL; BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF); CHEMICALLY INDUCED DISORDER; HIPPOCAMPUS; LONG-TERM POTENTIATION (LTP); MEMORY DISORDER; METABOLISM; METHODOLOGY; NERVE GROWTH FACTOR (NGF); REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION (RTMS); SPRAGUE DAWLEY RAT; CHEMICALLY INDUCED; MEMORY DISORDERS; PROCEDURES;

ANIMALIA; RATTUS;

ALZHEIMER'S DISEASE (AD); BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF); LONG-TERM POTENTIATION (LTP); NERVE GROWTH FACTOR (NGF); NMDA RECEPTOR; REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION (RTMS);

AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; HIPPOCAMPUS; MALE; MEMORY DISORDERS; MODELS, ANIMAL; NERVE GROWTH FACTOR; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84879262057     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2013.05.001     Document Type: Article

References (82)

1. Abe K., Fujimoto T., Akaishi T., Misawa M. Basolateral amygdala D1- and D2-dopaminergic system promotes the formation of long-term potentiation in the dentate gyrus of anesthetized rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33:552-556.
2. Adey W.R. Tissue interactions with nonionizing electromagnetic fields. Physiol. Rev. 1981, 61:435-514.
3. Ahmed Z., Wieraszko A. Modulation of learning and hippocampal, neuronal plasticity by repetitive transcranial magnetic stimulation (rTMS). Bioelectromagnetics 2006, 27:288-294.
4. Andersen P., Morris R.G.M., Amaral D.G., Bliss T.V.P., O'Keefe J. Synaptic plasticity in the hippocampus 2007, 343-474. The Hippocampus Book Oxford University Press.
5. Angelucci F., Oliviero A., Pilato F., Saturno E., Dileone M., Versace V., Musumeci G., Batocchi A.P., Tonali P.A., Di Lazzaro V. Transcranial magnetic stimulation and BDNF plasma levels in amyotrophic lateral sclerosis. Neuroreport 2004, 15:717-720.
6. Arancibia S., Silhol M., Mouliere F., Meffre J., Hollinger I., Maurice T., Tapia-Arancibia L. Protective effect of BDNF against beta-amyloid induced neurotoxicity in vitro and in vivo in rats. Neurobiol. Dis. 2008, 31:316-326.
7. Bai G., Kusiak J.W. Nerve growth factor up-regulates the N-methyl-d-aspartate receptor subunit 1 promoter in PC12 cells. J. Biol. Chem. 1997, 272:5936-5942.
8. Barker A.T. Electricity, magnetism and the body: some uses and abuses. J. R. Soc. Health 1994, 114:91-97.
9. Barker A.T., Jalinous R., et al. Non-invasive magnetic stimulation of human motor cortex. Lancet 1985, 1:1106-1107.
10. Bekinschtein P., Cammarota M., Izquierdo I., Medina J.H. BDNF and memory formation and storage. Neuroscientist 2008, 14:147-156.
11. Bentwich J., Dobronevsky E., Aichenbaum S., Shorer R., Peretz R., Khaigrekht M., Marton R.G., Rabey J.M. Beneficial effect of repetitive transcranial magnetic stimulation combined with cognitive training for the treatment of Alzheimer's disease: a proof of concept study. J. Neural Transm. 2011, 118:463-471.
12. Bersani F.S., Girardi N., et al. Deep Transcranial Magnetic Stimulation for treatment-resistant bipolar depression: A case report of acute and maintenance efficacy. Eur. Psychiatry 2012, 1-7. (ahead-of-print).
13. Bi H., Sze C.I. N-methyl-d-aspartate receptor subunit NR2A and NR2B messenger RNA levels are altered in the hippocampus and entorhinal cortex in Alzheimer's disease. J. Neurol. Sci. 2002, 200:11-18.
14. Blackman C.F., Benane S.G., Kinney L.S., Jones W.T., House D.E. Effect of ELF Fields on calcium-ion efflux from brain tissue in vitro. Radiat. Res. 1982, 92:510-520.
15. Bliss T.V.P., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993, 361:31-39.
16. Boroojerdi B., Phipps M., Kopylev L., Wharton C.M., Cohen L.G., Grafman J. Enhancing analogic reasoning with rTMS over the left prefrontal cortex. Neurology 2001, 56:526-528.
17. Bruel-Jungerman E., Davis S., Rampon C., Laroche S. Long-term potentiation enhances neurogenesis in the adult dentate gyrus. J. Neurosci. 2006, 26:5888-5893.
18. Bruno M.A., Leon W.C., Fragoso G., Mushynski W.E., Almazan G., Cuello A.C. Amyloid beta-induced nerve growth factor dysmetabolism in Alzheimer disease. J. Neuropathol. Exp. Neurol. 2009, 68:857-869.
19. Caldeira M.V., Melo C.V., Pereira D.B., Carvalho R.F., Carvalho A.L., Duarte C.B. BDNF regulates the expression and traffic of NMDA receptors in cultured hippocampal neurons. Mol. Cell. Neurosci. 2007, 35:208-219.
20. Calon F., Lim G.P., Morihara T., Yang F., Ubeda O., Salem N., Frautschy S.A., Cole G.M. Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer's disease. Eur. J. Neurosci. 2005, 22:617-626.
21. Christensen R., Marcussen A.B., Wortwein G., Knudsen G.M., Aznar S. Abeta(1-42) injection causes memory impairment, lowered cortical and serum BDNF levels, and decreased hippocampal 5-HT(2A) levels. Exp. Neurol. 2008, 210:164-171.
22. Colaianna M., Tucci P., Zotti M., Morgese M.G., Schiavone S., Govoni S., Cuomo V., Trabace L. Soluble beta amyloid(1-42): a critical player in producing behavioural and biochemical changes evoking depressive-related state?. Br. J. Pharmacol. 2010, 159:1704-1715.
23. Connor B., Dragunow M. The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res. Brain Res. Rev. 1998, 27:1-39.
24. Cooke S.F., Bliss T.V. Plasticity in the human central nervous system. Brain 2006, 129:1659-1673.
25. Cosgaya J.M., Latasa M.J., Pascual A. Nerve growth factor and ras regulate beta-amyloid precursor protein gene expression in PC12 cells. J. Neurochem. 1996, 67:98-104.
26. Covaceuszach S., Capsoni S., Ugolini G., Spirito F., Vignone D., Cattaneo A. Development of a non invasive NGF-based therapy for Alzheimer's disease. Curr. Alzheimer Res. 2009, 6:158-170.
27. Cullen W.K., Suh Y.H., Anwyl R., Rowan M.J. Block of LTP in rat hippocampus in vivo by beta-amyloid precursor protein fragments. Neuroreport 1997, 8:3213-3217.
28. Danielyan A.A., Mirakyan M.M., et al. The static magnetic field effects on ouabain H3 binding by cancer tissue. Physiol. Chem. Phys. Med. NMR 1999, 31:139-144.
29. Filali M., Lalonde R., Rivest S. Subchronic memantine administration on spatial learning, exploratory activity, and nest-building in an APP/PS1 mouse model of Alzheimer's disease. Neuropharmacology 2011, 60:930-936.
30. Foltys H., Sparing R., Boroojerdi B., Krings T., Meister I.G., Mottaghy F.M., Topper R. Motor control in simple bimanual movements: a transcranial magnetic stimulation and reaction time study. Clin. Neurophysiol. 2001, 112:265-274.
31. Fregni F., Pascual-Leone A. Transcranial magnetic stimulation for the treatment of depression in neurologic disorders. Curr. Psychiatry Rep. 2005, 7:381-390.
32. Freitas C., Mondragon-Llorca H., Pascual-Leone A. Noninvasive brain stimulation in Alzheimer's disease: systematic review and perspectives for the future. Exp. Gerontol. 2011, 46:611-627.
33. Gersner R., Kravetz E., Feil J., Pell G., Zangen A. Long-term effects of repetitive transcranial magnetic stimulation on markers for neuroplasticity: differential outcomes in anesthetized and awake animals. J. Neurosci. 2011, 31:7521-7526.
34. Gross M., Nakamura L., Pascual-Leone A., Fregni F. Has repetitive transcranial magnetic stimulation (rTMS) treatment for depression improved? A systematic review and meta-analysis comparing the recent vs. the earlier rTMS studies. Acta Psychiatr. Scand. 2007, 116:165-173.
35. Guerra A., Assenza F., Bressi F., Scrascia F., Del Duca M., Ursini F., Vollaro S., Trotta L., Tombini M., Chisari C., Ferreri F. Transcranial magnetic stimulation studies in Alzheimer's disease. Int. J. Alzheimers Dis. 2011, 2011:263817.
36. Haffen E., Chopard G., Pretalli J.B., Magnin E., Nicolier M., Monnin J., Galmiche J., Rumbach L., Pazart L., Sechter D., Vandel P. A case report of daily left prefrontal repetitive transcranial magnetic stimulation (rTMS) as an adjunctive treatment for Alzheimer disease. Brain Stimul. 2011, 5.3:264.
37. Harrison F.E., Hosseini A.H., McDonald M.P., May J.M. Vitamin C reduces spatial learning deficits in middle-aged and very old APP/PSEN1 transgenic and wild-type mice. Pharmacol. Biochem. Behav. 2009, 93:443-450.
38. Hayashi T., Ohnishi T., et al. Long-term effect of motor cortical repetitive transcranial magnetic stimulation. Ann. Neurol. 2004, 56:77-85.
39. Holsinger R.M., Schnarr J., Henry P., Castelo V.T., Fahnestock M. Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer's disease. Brain Res. Mol. Brain Res. 2000, 76:347-354.
40. Jarvis C.R., Xiong Z.G., Plant J.R., Churchill D., Lu W.Y., MacVicar B.A., MacDonald J.F. Neurotrophin modulation of NMDA receptors in cultured murine and isolated rat neurons. J. Neurophysiol. 1997, 78:2363-2371.
41. Kim Don-Kyu, Y.C.Y., Chae Soo Ahn, Seo Kyung Mook, Han Tai Ryoon, Kang Si-Hyun High-frequency magnetic stimulation attenuates beta-amyloid protein 1-42 neurotoxicity in organotypic hippocampal slices. Neural Regen. Res. 2010, 5:1365-1372.
42. Lanctot K.L., Herrmann N., Rothenburg L.S. Commentary: Abeta(1-42) injection causes memory impairment, lowered cortical and serum BDNF levels, and decreased hippocampal 5-HT2A levels. Exp. Neurol. 2008, 212:251-254.
43. Lessmann V., Gottmann K., Malcangio M. Neurotrophin secretion: current facts and future prospects. Prog. Neurobiol. 2003, 69:341-374.
44. Levkovitz Y., Grisaru N., et al. Transcranial magnetic stimulation and antidepressive drugs share similar cellular effects in rat hippocampus. Neuropsychopharmacology 2001, 24:608-616.
45. Liebetanz D., Fauser S., Michaelis T., Czeh B., Watanabe T., Paulus W., Frahm J., Fuchs E. Safety aspects of chronic low-frequency transcranial magnetic stimulation based on localized proton magnetic resonance spectroscopy and histology of the rat brain. J. Psychiatr. Res. 2003, 37:277-286.
46. Lu Y., Christian K., Lu B. BDNF: a key regulator for protein synthesis-dependent LTP and long-term memory?. Neurobiol. Learn. Mem. 2008, 89:312-323.
47. Muller M.B., Toschi N., Kresse A.E., Post A., Keck M.E. Long-term repetitive transcranial magnetic stimulation increases the expression of brain-derived neurotrophic factor and cholecystokinin mRNA, but not neuropeptide tyrosine mRNA in specific areas of rat brain. Neuropsychopharmacology 2000, 23:205-215.
48. Nagahara A.H., Merrill D.A., Coppola G., Tsukada S., Schroeder B.E., Shaked G.M., Wang L., Blesch A., Kim A., Conner J.M., Rockenstein E., Chao M.V., Koo E.H., Geschwind D., Masliah E., Chiba A.A., Tuszynski M.H. Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease. Nat. Med. 2009, 15:331-337.
49. Nilsson P., Iwata N., Muramatsu S., Tjernberg L.O., Winblad B., Saido T.C. Gene therapy in Alzheimer's disease - potential for disease modification. J. Cell Mol. Med. 2010, 14:741-757.
50. Nomura I., Takechi H., Kato N. Intraneuronally injected amyloid beta inhibits long-term potentiation in rat hippocampal slices. J. Neurophysiol. 2012, 107.9:2526-2531.
51. Ogiue-Ikeda M., Kawato S., et al. The effect of repetitive transcranial magnetic stimulation on long-term potentiation in rat hippocampus depends on stimulus intensity. Brain Res. 2003, 993:222-226.
52. O'Hare E., Weldon D.T., Mantyh P.W., Ghilardi J.R., Finke M.P., Kuskowski M.A., Maggio J.E., Shephard R.A., Cleary J. Delayed behavioral effects following intrahippocampal injection of aggregated A beta (1-42). Brain Res. 1999, 815:1-10.
53. Pastalkova E., Serrano P., Pinkhasova D., Wallace E., Fenton A.A., Sacktor T.C. Storage of spatial information by the maintenance mechanism of LTP. Science 2006, 313:1141-1144.
54. Pell G.S., Roth Y., et al. Modulation of cortical excitability induced by repetitive transcranial magnetic stimulation. Prog. Neurobiol. 2011, 93:59-98.
55. Pennisi G., Ferri R., Cantone M., Lanza G., Pennisi M., Vinciguerra L., Malaguarnera G., Bella R. A review of transcranial magnetic stimulation in vascular dementia. Dement. Geriatr. Cogn. Disord. 2011, 31:71-80.
56. Pilato F., Profice P., et al. Synaptic plasticity in neurodegenerative diseases evaluated and modulated by in vivo neurophysiological techniques. Mol. Neurobiol 2012, 46.3:563-571.
57. Post A., Muller M.B., Engelmann M., Keck M.E. Repetitive transcranial magnetic stimulation in rats: evidence for a neuroprotective effect in vitro and in vivo. Eur. J. Neurosci. 1999, 11:3247-3254.
58. Shankar G.M., Walsh D.M. Alzheimer's disease: synaptic dysfunction and Abeta. Mol. Neurodegener. 2009, 4:48.
59. Shin R.W., Ogino K., Kondo A., Saido T.C., Trojanowski J.Q., Kitamoto T., Tateishi J. Amyloid beta-protein (Abeta) 1-40 but not Abeta1-42 contributes to the experimental formation of Alzheimer disease amyloid fibrils in rat brain. J. Neurosci. 1997, 17:8187-8193.
60. Siebner H.R., Lang N., Rizzo V., Nitsche M.A., Paulus W., Lemon R.N., Rothwell J.C. Preconditioning of low-frequency repetitive transcranial magnetic stimulation with transcranial direct current stimulation: evidence for homeostatic plasticity in the human motor cortex. J. Neurosci. 2004, 24:3379-3385.
61. Spritzer M.D., Daviau E.D., Coneeny M.K., Engelman S.M., Prince W.T., Rodriguez-Wisdom K.N. Effects of testosterone on spatial learning and memory in adult male rats. Horm. Behav. 2011, 59:484-496.
62. Tan T., Zhang B.L., Tian X. Chronic effects of oligomeric Abeta(1-42) on hippocampal synaptic plasticity in vivo. Sheng Li Xue Bao 2011, 63:225-232.
63. Tang Y.P., Shimizu E., Dube G.R., Rampon C., Kerchner G.A., Zhuo M., Liu G., Tsien J.Z. Genetic enhancement of learning and memory in mice. Nature 1999, 401:63-69.
64. Tian L., Guo R., Yue X., Lv Q., Ye X., Wang Z., Chen Z., Wu B., Xu G., Liu X. Intranasal administration of nerve growth factor ameliorate beta-amyloid deposition after traumatic brain injury in rats. Brain Res. 2012, 1440:47-55.
65. Todd G., Flavel S.C., Ridding M.C. Low-intensity repetitive transcranial magnetic stimulation decreases motor cortical excitability in humans. J. Appl. Physiol. 2006, 101:500-505.
66. Tokay T., Holl N., Kirschstein T., Zschorlich V., Kohling R. High-frequency magnetic stimulation induces long-term potentiation in rat hippocampal slices. Neurosci. Lett. 2009, 461:150-154.
67. Tong Z., Han C., Luo W., Wang X., Li H., Luo H., Zhou J., Qi J., He R. Accumulated hippocampal formaldehyde induces age-dependent memory decline. Age 2013, 35:583-596.
68. Trippe J., Mix A., et al. theta burst and conventional low-frequency rTMS differentially affect GABAergic neurotransmission in the rat cortex. Exp. Brain Res. 2009, 199:411-421.
69. Tsang S.W., Vinters H.V., Cummings J.L., Wong P.T., Chen C.P., Lai M.K. Alterations in NMDA receptor subunit densities and ligand binding to glycine recognition sites are associated with chronic anxiety in Alzheimer's disease. Neurobiol. Aging 2008, 29:1524-1532.
70. Wang F., Geng X., Tao H.Y., Cheng Y. The restoration after repetitive transcranial magnetic stimulation treatment on cognitive ability of vascular dementia rats and its impacts on synaptic plasticity in hippocampal CA1 area. J. Mol. Neurosci. 2010, 41:145-155.
71. Wang H.Y., Crupi D., Liu J., Stucky A., Cruciata G., Di Rocco A., Friedman E., Quartarone A., Ghilardi M.F. Repetitive transcranial magnetic stimulation enhances BDNF-TrkB signaling in both brain and lymphocyte. J. Neurosci. 2011, 31:11044-11054.
72. Wassermann E.M. Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5-7, 1996. Electroencephalogr. Clin. Neurophysiol. 1998, 108:1-16.
73. Wassermann E.M., Zimmermann T. Transcranial magnetic brain stimulation: therapeutic promises and scientific gaps. Pharmacol. Ther. 2012, 133:98-107.
74. Wassermann E.M., Grafman J., Berry C., Hollnagel C., Wild K., Clark K., Hallett M. Use and safety of a new repetitive transcranial magnetic stimulator. Electroencephalogr. Clin. Neurophysiol. 1996, 101:412-417.
75. Weskamp G., Otten U. An enzyme-linked immunoassay for nerve growth factor (NGF): a tool for studying regulatory mechanisms involved in NGF production in brain and in peripheral tissues. J. Neurochem. 1987, 48:1779-1786.
76. Whitlock J.R., Heynen A.J., Shuler M.G., Bear M.F. Learning induces long-term potentiation in the hippocampus. Science 2006, 313:1093-1097.
77. Wu A.D., Fregni F., Simon D.K., Deblieck C., Pascual-Leone A. Noninvasive brain stimulation for Parkinson's disease and dystonia. Neurotherapeutics 2008, 5:345-361.
78. Yukimasa T., Yoshimura R., Tamagawa A., Uozumi T., Shinkai K., Ueda N., Tsuji S., Nakamura J. High-frequency repetitive transcranial magnetic stimulation improves refractory depression by influencing catecholamine and brain-derived neurotrophic factors. Pharmacopsychiatry 2006, 39:52-59.
79. Zafra F., Lindholm D., Castren E., Hartikka J., Thoenen H. Regulation of brain-derived neurotrophic factor and nerve growth factor mRNA in primary cultures of hippocampal neurons and astrocytes. J. Neurosci. 1992, 12:4793-4799.
80. Zanardini R., Gazzoli A., Ventriglia M., Perez J., Bignotti S., Rossini P.M., Gennarelli M., Bocchio-Chiavetto L. Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients. J. Affect. Disord. 2006, 91:83-86.
81. Zhang X., Mei Y., Liu C., Yu S. Effect of transcranial magnetic stimulation on the expression of c-Fos and brain-derived neurotrophic factor of the cerebral cortex in rats with cerebral infarct. J. Huazhong Univ. Sci. Technol. Med. Sci. 2007, 27:415-418.
82. Zhou J.P., Feng Z.G., Yuan B.L., Yu S.Z., Li Q., Qu H.Y., Sun M.J. Transduced PTD-BDNF fusion protein protects against beta amyloid peptide-induced learning and memory deficits in mice. Brain Res. 2008, 1191:12-19.